An important tool in lymphedema management: Validation of Turkish version of the patient benefit index-lymphedema

Basit Öğe Kaydı
dc.authorscopusid57190401503
dc.authorscopusid12785299300
dc.authorscopusid6701531347
dc.authorwosidBakar, Yesim/AAR-2311-2021
dc.contributor.authorDuygu, Elif
dc.contributor.authorBakar, Yeşim
dc.contributor.authorKeser, İlke
dc.date.accessioned2022-02-15T16:57:36Z
dc.date.available2022-02-15T16:57:36Z
dc.date.issued2020
dc.departmentBakırçay Üniversitesien_US
dc.description.abstractBackground: The aim of this study was to investigate the Turkish adaptation, validity, and reliability of the Patient Benefit Index-Lymphedema (PBI-L) ensuring direct assessment of the benefit in patients with lymphedema (LE), lipedema, and lipolymphedema. Methods and Results: Eighty-one patients who were consulted for physiotherapy, whose diagnoses were LE, lipedema, and lipolymphedema, and who were treated or planned to be treated for these diagnoses, were included in this study. PBI-L was adapted to Turkish by considering the stages of the cultural adaptation process. Short Form-36 (SF-36) was applied for the validity of PBI-L. PBI-L was repeated after a 1-week interval for test-retest reliability. The mean age was 47.66 +/- 14.23 years. The intraclass correlation coefficient (ICC) value was determined as 0.73 (p < 0.0001) for the total score. There was a moderate correlation between first (ICC = 0.63, p < 0.0001) and second subdimensions (ICC = 0.62, p < 0.0001). Cronbach's alpha values ranged between 0.83 and 0.89. Low correlations were found between total scores of PBI-L and mental health, physical function subdimensions of SF-36 (p < 0.05). The Kaiser Meyer Olkin value was 0.6, and it was found that the PBI-L was not consistent with factor analysis. Conclusion: The Turkish version of PBI-L is a valid and reliable tool in patients with LE, lipedema, and lipolymphedema. However, the reassessment validity of PBI-L would be suggested by using an LE-specific quality of life questionnaire.en_US
dc.identifier.doi10.1089/lrb.2018.0036
dc.identifier.endpage55en_US
dc.identifier.issn1539-6851
dc.identifier.issn1557-8585
dc.identifier.issue1en_US
dc.identifier.pmid31145018en_US
dc.identifier.scopus2-s2.0-85081138206en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage49en_US
dc.identifier.urihttps://doi.org/10.1089/lrb.2018.0036
dc.identifier.urihttps://hdl.handle.net/20.500.14034/218
dc.identifier.volume18en_US
dc.identifier.wosWOS:000469515600001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.journalLymphatic Research And Biologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectpatient-reported outcomeen_US
dc.subjectlipedemaen_US
dc.subjectlymphedema assessmenten_US
dc.subjectTurkish adaptationen_US
dc.subjectQuality-Of-Lifeen_US
dc.subjectLower-Limb Lymphedemaen_US
dc.subjectHealth Questionnaireen_US
dc.subjectPsychosocial Impacten_US
dc.subjectReliabilityen_US
dc.subjectTranslationen_US
dc.subjectDisabilityen_US
dc.titleAn important tool in lymphedema management: Validation of Turkish version of the patient benefit index-lymphedemaen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
An important tool in lymphedema management.pdf
Boyut:
248.85 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Fizyoterapi ve Rehabilitasyon Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu